Astrea Bioseparations

Since 1987, Astrea Bioseparations has been pioneering the design, development and manufacture of affinity purification technology for lab-scale and industrial-scale bioprocessing. With over 25 years experience and success in the development of affinity products and design of new custom adsorbents, Astrea is a world leader in its field. Astrea Bioseparations has sales and support offices in North America and Europe, R&D facilities in Cambridge, UK and manufacturing facilities located on the Isle of Man, British Isles and Joliette, QC, Canada ensuring that we are able to meet your needs and support your application wherever you are. OUR EXPERTISE: Extensive range...

Protein purification,plasma proteins,biosimilars,recombinant proteins,pathogen reduction,bio-contaminant removal,downstream process development,and custom adsorbent development

Astrea bioseparations operates in the Biotechnology research industry.

Astrea bioseparations's revenue is 11m - 100m

Astrea bioseparations has 51 - 200 employees.